Alexandria Pharmaceuticals wins 108.2 million pounds within 9 months

1
Facebook
Twitter
Pinterest
WhatsApp
Telegram

The profits of the “Alexandria Pharmaceuticals and Chemical Industries” company decreased by 19.5% during the nine months of the current fiscal year to reach 108.2 million pounds, compared to a net profit of 134.4 million pounds during the same period of the previous fiscal year 2019-2020.

While the company’s sales increased during the nine months to reach 890.3 million pounds by the end of March, compared to total revenues of 799.5 million pounds during the same period of the previous fiscal year, and the total profit during the same period decreased to 218.9 million pounds compared to a total profit of 254.1 million pounds in the same period.

Alexandria Company for Drugs and Chemical Industries decreased by 19.3% during the first 8 months of the current fiscal year to reach 95.3 million pounds, compared to a net profit of 118.1 million pounds during the same period of the last fiscal year 2019-2020.

The company’s revenues increased during the eight months to reach 787.7 million pounds, compared to 709.03 million pounds during the same period last fiscal year.

Earlier, the Board of Directors of the Alexandria Company for Drugs and Chemical Industries decided to reduce the targets for the estimated budget for the current fiscal year 2020-2021.

The board of directors agreed to reduce the sales targets in the current fiscal year budget from 1.33 billion pounds to 1.2 billion pounds.

The company also reduced its net profit target during the current fiscal year to 170 million pounds, compared to 196.5 million pounds.

The Ordinary General Assembly of Alexandria Pharmaceuticals and Chemical Industries last April approved the estimated budget for the next fiscal year (2020-2021), with targeted profits of 196.5 million pounds in the next fiscal year, compared to targeted profits of 147 million pounds in the last fiscal year.

The general assembly recommended management to reconsider the budget whenever necessary.

The profits of “Alexandria Pharmaceuticals and Chemical Industries” decreased by 7.34% during the first half of the current fiscal year, to reach 79 million pounds, compared to a net profit of 85.26 million pounds in the comparative year 2019.

Sales increased to reach 580.2 million pounds during the period from July to 31 December last, compared to total sales of 531.4 million pounds in the comparative period.

The general assembly of “Alexandria Pharmaceuticals and Chemical Industries” approved the increase in the cash distribution value of the share to 15.5 pounds for the fiscal year 2019-2020, raising the value of the coupon from the proposed dividend of 11.5 pounds per share.

The general assembly approved the employees ‘share of profits at 23.13 million pounds, and the board of directors’ share of 810 thousand pounds, distributed equally between the chairman and the members.

The Assembly also approved the Board of Directors’ report on the company’s activities and its financial position for the last fiscal year.

The proposal to distribute the profits of Alexandria for the pharmaceutical and chemical industries for the fiscal year 2019-2020 showed a proposal to distribute 11.5 pounds per share.

The company achieved profits amounting to 170.04 million pounds during the fiscal year ending last June, compared to 112.8 million pounds in the previous fiscal year.

The company’s sales increased during the last fiscal year to 1.02 billion pounds, compared to sales of 829 million pounds in the previous fiscal year.

The company has a capital of 50 million pounds, divided into 5 million shares, with a nominal value of 10 pounds per share.

 

The article “Alexandria Pharmaceuticals” wins 108.2 million pounds in 9 months, it was written in the Al-Borsa newspaper.